Experiências e expectativas de enfermeiros no cuidado ao doador de órgãos e à sua família

RESUMO Objetivo Compreender as experiências e expectativas dos enfermeiros de unidades de terapia intensiva no cuidado ao doador de órgãos para transplantes e à sua família. Método Pesquisa qualitativa, com abordagem da Fenomenologia Social realizada em 2013, com 20 enfermeiros. Resultados As experiências dos enfermeiros com as famílias dos doadores foram representadas pelas categorias: obstáculos vivenciados e intervenções realizadas no cuidado às famílias dos doadores. As expectativas desses profissionais na assistência às famílias e aos doadores de órgãos foram descritas pela categoria: cuidar para salvar vidas. Conclusão O estudo mostrou que o cotidiano dos enfermeiros de terapia intensiva no cuidado às famílias e aos doadores de órgãos é permeado por obstáculos que interferem no processo de doação. Diante desse cenário têm como expectativas oferecer uma assistência intensiva ao doador falecido e um cuidado humanizado às famílias, intencionando possibilitar a aceitação da doação de órgãos pelos familiares e viabilizar órgãos para transplantes

Financial considerations in the conduct of multi-centre randomised controlled trials: evidence from a qualitative study.

National Coordinating Centre for Research Methodology; Medical Research Council, UK Department of Health; Chief Scientist OfficeNot peer reviewedPublisher PD

Association of shared decision-making with type of breast cancer surgery: a cross-sectional study

<p>Abstract</p> <p>Background</p> <p>Although some studies examined the association between shared decision-making (SDM) and type of breast cancer surgery received, it is little known how treatment decisions might be shaped by the information provided by physicians. The purpose of this study was to identify the associations between shared decision making (SDM) and surgical treatment received.</p> <p>Methods</p> <p>Questionnaires on SDM were administered to 1,893 women undergoing primary curative surgery for newly diagnosed stage 0-II localized breast cancer at five hospitals in Korea. Questions included being informed on treatment options and the patient's own opinion in decision-making.</p> <p>Results</p> <p>Patients more likely to undergo mastectomy were those whose opinions were respected in treatment decisions (adjusted odds ratio, aOR), 1.40; 95% confidence interval (CI), 1.14-1.72) and who were informed on chemotherapy (aOR, 2.57; CI, 2.20-3.01) or hormone therapy (aOR, 2.03; CI, 1.77-2.32). In contrast, patients less likely to undergo mastectomy were those who were more informed on breast surgery options (aOR, 0.34; CI, 0.27-0.42). In patients diagnosed with stage 0-IIa cancer, clinical factors and the provision of information on treatment by the doctor were associated with treatment decisions. In patients diagnosed with stage IIb cancer, the patient's opinion was more respected in treatment decisions.</p> <p>Conclusion</p> <p>Our population-based study suggested that women's treatment decisions might be shaped by the information provided by physicians, and that women might request different information from their physicians based on their preferred treatment options. These results might need to be confirmed in other studies of treatment decisions.</p

The patient experience

The impact of improved treatments for the management of hormone-sensitive breast cancer extends beyond clinical responses. Thanks to appropriate literature and access to the internet, patient awareness of treatment options has grown and patients are now, in many cases, able to engage their oncologists in informed conversations regarding treatment and what to expect in terms of efficacy and safety. Indeed, patients realize that although there is no cure for metastatic disease, treatment can greatly reduce the risk of progression and in the adjuvant setting, where treatment is administered with a curative intent, current treatment options reduce the risk of relapse. The approval of letrozole throughout the breast cancer continuum has provided patients with many reassuring options. The improvement in outcome with letrozole is achieved without a detrimental effect on overall quality of life. Adverse events such as hot flushes, arthralgia, vaginal dryness, and potential osteoporosis are most significant from the patient’s perspective, and it is important that caregivers pay attention to patients experiencing these events, as they can impact compliance unless effectively explained and managed. The major benefits of letrozole are to improve prospects for long-term survivorship in the adjuvant setting and to delay progression and the need for chemotherapy in the metastatic setting

Governance quality indicators for organ procurement policies

We would like to thank all members of the ISSATO working group for data collection coordination: Gabriele Werner-Felmayer and Magdalena Flatscher-Tho¨ni (Austria), Kristof van Assche (Belgium), Anja Jensen (Denmark), Thalia Bellali (Greece), and Tanja Kamin (Slovenia). We are also thankful to other members of the ELPAT-ESOT (Ethical, Legal and Psychosocial Aspects of Transplantation-European Society of Organ Transplantation) for their help in shaping the questionnaire: Hagai Boas, Myfanwy Morgan, and Gurch Randhawa. Yolanda Ramallo Fariña and Miguel Angel Garcı´a Bello helped us with methodological advice. Finally, we thank ELPAT-ESOT board for organizing working-group meetings between 2016 and 2018.Background Consent policies for post-mortem organ procurement (OP) vary throughout Europe, and yet no studies have empirically evaluated the ethical implications of contrasting consent models. To fill this gap, we introduce a novel indicator of governance quality based on the ideal of informed support, and examine national differences on this measure through a quantitative survey of OP policy informedness and preferences in seven European countries. Methods Between 2017–2019, we conducted a convenience sample survey of students (n = 2006) in Austria (AT), Belgium (BE), Denmark (DK), Germany (DE), Greece (GR), Slovenia (SI) and Spain (ES), asking participants about their donation preferences, as well as their beliefs and views about the policy in place. From these measures, we computed indices of informedness, policy support, and fulfilment of unexpressed preferences, which we compared across countries and consent systems. Results Our study introduces a tool for analyzing policy governance in the context of OP. Wide variation in policy awareness was observed: Most respondents in DK, DE, AT and BE correctly identified the policy in place, while those in SI, GR and ES did not. Respondents in opt-out countries (AT, BE, ES and GR) tended to support the policy in place (with one exception, i.e., SI), whereas those in opt-in countries (DE and DK) overwhelmingly opposed it. These results reveal stark differences in governance quality across countries and consent policies: We found a preponderance of informed opposition in opt-in countries and a general tendency towards support–either informed or uninformed–in opt-out countries. We also found informed divergence in opt-in countries and a tendency for convergence–either informed or uninformed–among opt-out countries. Conclusion Our study offers a novel tool for analyzing governance quality and illustrates, in the context of OP, how the strengths and weaknesses of different policy implementations can be estimated and compared using quantitative survey data.MINECO FFI2017-88913-P Ministerio de Economía y Competitivida